Follow
Yinnong Jia
Title
Cited by
Cited by
Year
Nitrendipine Nanocrystals: Its Preparation, Characterization, and In Vitro–In Vivo Evaluation
P Quan, D Xia, H Piao, H Piao, K Shi, Y Jia, F Cui
AAPS PharmSciTech 12, 1136-1143, 2011
592011
Synthesis and in vitro and in vivo evaluation of hypoxia-enhanced 111In-bombesin conjugates for prostate cancer imaging
Z Zhou, NK Wagh, SM Ogbomo, W Shi, Y Jia, SK Brusnahan, JC Garrison
Journal of Nuclear Medicine 54 (9), 1605-1612, 2013
322013
Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting
Y Jia, W Shi, Z Zhou, NK Wagh, W Fan, SK Brusnahan, JC Garrison
Nuclear medicine and biology 42 (11), 816-823, 2015
272015
Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancer
W Fan, W Shi, W Zhang, Y Jia, Z Zhou, SK Brusnahan, JC Garrison
Biomaterials 103, 101-115, 2016
252016
The influence of linker length on the properties of cathepsin S cleavable 177Lu-labeled HPMA copolymers for pancreatic cancer imaging
W Shi, SM Ogbomo, NK Wagh, Z Zhou, Y Jia, SK Brusnahan, JC Garrison
Biomaterials 35 (22), 5760-5770, 2014
252014
Investigation into the biological impact of block size on cathepsin S-degradable HPMA copolymers
W Fan, W Zhang, Y Jia, SK Brusnahan, JC Garrison
Molecular pharmaceutics 14 (5), 1405-1417, 2017
122017
Investigation of the biological impact of charge distribution on a NTR1-targeted peptide
Y Jia, W Zhang, W Fan, S Brusnahan, J Garrison
Bioconjugate chemistry 27 (11), 2658-2668, 2016
102016
Synthesis and characterization of hypoxia trapping incorporated 177Lu-bombesin analogs for prostate cancer
Z Zhou, N Wagh, W Shi, Y Jia, S Brusnahan, J Garrison
Journal of Nuclear Medicine 55 (supplement 1), 64-64, 2014
12014
Development of Neurotensin-Based Radiopharmaceuticals For Neurotensin-Receptor-1-Positive Tumors Targeting
Y Jia
2017
177Lu-labeled NTR1-targeted peptide for cancer diagnosis and therapy: the effect of charge distribution on the receptor binding and kidney retention
Y Jia, W Fan, W Zhang, S Brusnahan, J Garrison
Journal of Nuclear Medicine 57 (supplement 2), 1375-1375, 2016
2016
Evaluation of DOTA-chelated neurotensin analogs with a spacer for targeting of neurotensin receptor 1 positive tumors
Y Jia, W Shi, Z Zhou, N Wagh, S Brusnahan, J Garrison
Journal of Nuclear Medicine 56 (supplement 3), 1159-1159, 2015
2015
Hypoxia trapping 177Lu-labeled Bombesin conjugates: Design, synthesis and in vitro studies in PC-3 human prostate tumor cell
N Wagh, Z Zhou, W Shi, Y Jia, S Brusnahan, J Garrison
Journal of Nuclear Medicine 55 (supplement 1), 392-392, 2014
2014
Development of cathepsin cleavable HPMA copolymer for enhanced tumor imaging and radiotherapy
W Shi, N Wagh, Z Zhou, Y Jia, S Brusnahan, J Garrison
Journal of Nuclear Medicine 54 (supplement 2), 1397-1397, 2013
2013
Development and evaluation of hypoxia-enhanced 177Lu-labeled bombesin conjugates for prostate cancer
N Wagh, Z Zhou, W Shi, Y Jia, S Brusnahan, J Garrison
Journal of Nuclear Medicine 54 (supplement 2), 330-330, 2013
2013
The system can't perform the operation now. Try again later.
Articles 1–14